ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

September issue of Business & Regulatory Report included (8-page issue).

October 4, 2002

Trials Approved by NCI CTEP For the Month of January

January 27, 2012

Evaluation Finds OIG Provides PIs With Flexibility

June 14, 1991

NCI Bypass Budget For FY 1992 Requests $2.6 Billion Support grows In Congress

May 18, 1990

ASCO Recommends Against Chemo In Stage II Colon Cancer

June 25, 2004

Reviewers Duck Problem Of Naming Four More Comprehensive Centers, Leave It Up To Rauscher To Pick From List Of 11

March 29, 1974